Heather Lounsbury
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Monoclonal and Polyclonal Antibodies Research, Synthesis and Reactions of Organic Compounds, Lymphoma Diagnosis and Treatment, HER2/EGFR in Cancer Research
Most-Cited Works
- → Rates and Mechanism of Fe(II) Oxidation at Nanomolar Total Iron Concentrations(1995)344 cited
- → Inhibition of Btk with CC-292 Provides Early Pharmacodynamic Assessment of Activity in Mice and Humans(2013)219 cited
- → Phase Ib trial of AVL-292, a covalent inhibitor of Bruton's tyrosine kinase (Btk), in chronic lymphocytic leukemia (CLL) and B-non-Hodgkin lymphoma (B-NHL).(2012)32 cited
- → Synthesis of CMI-977, a Potent 5-Lipoxygenase Inhibitor(1998)27 cited
- → Clinical Development of AVL-292; A Potent, Selective Covalent Btk Inhibitor for the Treatment of B Cell Malignancies,(2011)20 cited
- → 2.23 Covalent Inhibition of Btk with Clinical Development Compound AVL-292 Disrupts Signaling That Maintains the Microenvironment Necessary for Chronic Lymphocytic Leukemia Growth(2011)12 cited
- → Abstract 1745: Translational medicine enables rapid early clinical development of AVL-292, a highly selective, orally available inhibitor of Bruton's tyrosine kinase, in a phase 1b clinical trial(2012)4 cited
- → ChemInform Abstract: Synthesis of CMI‐977, a Potent 5‐Lipoxygenase Inhibitor.(1999)